Last deal

$8.1M

Amount

Series D

Stage

15.04.2010

Date

3

all rounds

$51.57M

Total amount

date founded

Financing round

General

About Company
DIREVO develops and optimizes biocatalysts for various industries using its proprietary ultra-high-throughput screening platform.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2000

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

The privately-owned company focuses on the biomass conversion industry, identifying bottlenecks and weaknesses in current industrial processes and developing biology-based solutions in conjunction with industrial partners, such as Genencor, AB Enzymes, and Nestlé, for use in non-pharmaceutical industries. Its shareholders include Wölbern EquityPartner, NRW Bank, TVM Capital, Danisco A/S, SandersMorrisHarris Enzymes LLC, Mulligan BioCapital, and several private investors.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000

Genencore

Genencor develops innovative enzymes and bio-based solutions for various industries.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Wilmington, DE, USA
Evolugate

Evolugate

Evolugate is a biotechnology company that improves the bio conversion capabilities of microorganisms for various industrial purposes.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Gainesville, FL, USA

total rounds

1

total raised

$240.2K
GlobalYeast

GlobalYeast

GlobalYeast is a biotech startup that develops and deploys fermentation solutions.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

São Paulo, State of São Paulo, Brazil

total rounds

1

total raised

$6.77M
ProcessHQ

ProcessHQ

ProcessHQ, Inc. is a vertically integrated bioprocess solutions provider.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Manufacturing, Biotechnology

Location

Burbank, CA, USA
M&A Details
1

Acquired by

Bayer HealthCare

announced date

16.09.2008

price

$297.61M
Local Amount - EUR 210M

Financials

Funding Rounds
5
3

Number of Funding Rounds

$51.57M

Money Raised

Their latest funding was raised on 15.04.2010. Their latest investor Danish Venture Capital and Private Equity Association. Their latest round Series D

Date 
Funding Round 
Investors 
Money Raised 
Lead 
15.04.2010
2
$8.1M
01.02.2010
2
$8.35M
Local Amount - EUR 6M
18.10.2007
7
$16.8M
NRW.BANK

NRW.BANK

NRW.BANK is a financial group that supports investment and development in the NRW state of Germany.

Sector

Banks

Subsector

Banks

Keywords

Financial Services, Venture Capital, Finance

Location

Düsseldorf, Germany

count Of Investments

83

count Of Exists

11
TVM Capital

TVM Capital

TVM Capital is a venture capital firm that focuses on investing in biopharmaceutical and medical device companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Financial Services, Venture Capital

Location

Munich, Germany

count Of Investments

86

count Of Exists

26
Co-Investors
Investors
9
3

Number of lead investors

9

Number of investors

Investor 
Lead 
Round 
Partners 
Danish Venture Capital and Private Equity Association

Danish Venture Capital and Private Equity Association

Danish venture capital firm invests in startups in Natural Resources and Dietary Supplements.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services, Association

Location

Copenhagen, Denmark

count Of Investments

3

count Of Exists

2
Sanders Morris Harris

Sanders Morris Harris

Sanders Morris Harris is a Houston-based financial services firm that offers investment and advisory services.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

Houston, TX, USA

count Of Investments

11

count Of Exists

6
Mulligan BioCapital

Mulligan BioCapital

Mulligan BioCapital is a German investment firm focused on biotechnology and healthcare applications.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Biotechnology, Health Care, Venture Capital

Location

Hamburg, Germany

count Of Investments

6

count Of Exists

2

People

Employee Profiles
6
Hubert Birner

Hubert Birner

Chairman/Vice Chairman(Cologne, Germany)

Andreas Lischka

Vice President Finance & Administration

Jörg Riesmeier

Jörg Riesmeier

CEO

Thomas von Rueden

CEO

Activity

Recent News
0